跳至主要内容
临床试验/NCT01923493
NCT01923493已完成不适用

Chronic Neck Pain: a Randomized Controlled Trial in Patients With Chronic Neck Pain Comparing Tuina vs. no Intervention Waiting List

Charite University, Berlin, Germany1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2013年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
92
试验地点
1
主要终点
mean neck pain intensity of the last seven days

研究概览

简要总结

The aim is to evaluate whether tuina is more effective and cost-effective than no intervention waiting list to reduce neck pain measured on a visual analogue scale in patients suffering from chronic neck pain.

详细描述

Objective

To evaluate whether tuina is more effective and cost-effective than no intervention waiting list to reduce neck pain measured on a visual analogue scale in patients suffering from chronic neck pain.

Study Design: Open single-centre randomized two-armed controlled trial. Setting: The study will be performed at a University out-patient clinic specialized in Integrative Medicine, with experience in the treatment of chronic pain.

Participants: 88 outpatients with chronic neck pain, who will be randomly allocated to two groups (tuina, or no intervention (control)).

Intervention: Patients receive either six tuina treatments within 3 weeks or no additional intervention.

Main outcome measure: The primary outcome is the mean neck pain intensity over the last seven days on a visual analogue scale (Huskisson, 1974) (VAS, 0-100 mm, 0 = no pain, 100= worst imaginable pain) after four weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •female or male
  • •18 to 60 years of age
  • •clinical diagnosis "chronic neck pain", i.e. neck pain for at least 12 weeks
  • •if additional back pain is reported, neck pain has to be predominant
  • •intensity of the average neck pain over the last 7 days had to be more than 40 mm on a 100-mm visual analogue scale (VAS)
  • •ability to give oral and signed written informed consent
  • •patient's mental and physical ability to participate in the trial
  • •willingness to be randomized, to attend visits, to complete questionnaires
  • •written and oral informed consent

排除标准

  • •neck pain caused by a malignant disease
  • •neck pain caused by trauma
  • •rheumatic disorder
  • •prior spinal column surgery
  • •neurological symptoms, e.g. radicular symptoms because of a prolapsed vertebral disc
  • •suspected osteoporosis
  • •obesity with BMI ≥30 Kg/m2
  • •known vascular anomaly such as aneurysm
  • •regular intake of analgesics (>1x per week) because of a additional diseases
  • •intake of centrally acting analgesics
  • •current application for a benefit
  • •pregnancy
  • •severe acute and or chronic disease which does not allow participation in the therapy
  • •other limitations which do not allow participation in the therapy
  • •alcohol or substance abuse
  • •tuina treatment during the six months before study entry
  • •participation in another clinical trial during six months before the study and parallel to the study
  • •anticipated new treatments which have a positive influence on the neck pain such as physiotherapy against neck pain, acupuncture, massage during the study
  • •no sufficient German language skills

研究组 & 干预措施

tuina

Experimental

tuina treatment

干预措施: tuina (Other)

no intervention waiting list

Active Comparator

Patients in the no intervention waiting list group will not receive a study intervention.

干预措施: no intervention (Other)

结局指标

主要结局

mean neck pain intensity of the last seven days

时间窗: 4 weeks

次要结局

  • mean neck pain intensity of the last seven days(12 weeks)
  • SF-12 health related quality of life(4 weeks, 12 weeks)
  • Neck Pain and Disability Scale (NPDS)(4 weeks, 12 weeks)
  • Costs(4 weeks, 12 weeks)
  • Body efficacy expectation(4 weeks, 12 weeks)
  • number of serious adverse events(4 weeks, 12 weeks)
  • Neck Disability Index (NDI)(4 weeks, 12 weeks)
  • medication intake(4 weeks, 12 weeks)
  • adverse reactions(4 weeks, 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Claudia M. Witt

Prof. Dr. med.

Charite University, Berlin, Germany

研究点 (1)

Loading locations...

相似试验